A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer’s Disease: Investigating Structure through Docking Studies
c-Jun N-terminal kinase (JNK) plays an important role in cell death caused by various stimuli. Because the isoform JNK3 is mainly expressed in the brain, it is believed to play a pivotal role in various neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD), whic...
Main Authors: | Hyunwook Cho, Jung-Mi Hah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/10/1431 |
Similar Items
-
Identification of potent schistosomicidal compounds predicted as type II-kinase inhibitors against Schistosoma mansoni c-Jun N-terminal kinase SMJNK
by: Bernardo P. Moreira, et al.
Published: (2024-04-01) -
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
by: Men Thi Hoai Duong, et al.
Published: (2020-01-01) -
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats
by: Mark B. Plotnikov, et al.
Published: (2019-05-01) -
Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis
by: Benjamin Lai, et al.
Published: (2020-11-01) -
Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes
by: Justin Hou Ming Yung, et al.
Published: (2020-03-01)